Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption. [electronic resource]
Producer: 20010126Description: 306-14 p. digitalISSN:- 1522-8002
- Animals
- Antibodies -- therapeutic use
- Brain Neoplasms -- blood supply
- Endothelial Growth Factors -- antagonists & inhibitors
- Female
- Glioblastoma -- blood supply
- Humans
- In Situ Nick-End Labeling
- Lymphokines -- antagonists & inhibitors
- Neovascularization, Pathologic -- prevention & control
- Rats
- Rats, Nude
- Survival Rate
- Time Factors
- Transplantation, Heterologous
- Tumor Cells, Cultured
- Vascular Endothelial Growth Factor A
- Vascular Endothelial Growth Factors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.